No such alleviation was observed in the NPC-CM group where the counts of CD68+ and CD11b+ cells in the damaged area were significantly higher compared with the GPC-CM group (Figure 5a,b). The gene discussed is ITGAM; the disease is nasopharyngeal carcinoma.